Fair Value Measurements

6 Months Ended

Jun. 30, 2018

Financial Instruments, Owned, at Fair Value [Abstract]

Financial assets and liabilities measured at fair value on a recurring basis in the consolidated balance sheets are immaterial at June 30, 2018.

The table below summarizes the carrying amounts and fair values of the Company’s financial instruments (in thousands):



	June 30, 2018⁽³⁾				December 31, 2017⁽³⁾
	Carrying Value		Fair Value		Carrying Value		Fair Value
Loans receivable, net⁽²⁾	$	38,691	$	38,579	$	313,326	$	313,242
Marketable debt securities⁽²⁾	18,941		18,941		18,690		18,690
Bank line of credit⁽²⁾	545,226		545,226		1,017,076		1,017,076
Term loan⁽²⁾	222,923		222,923		228,288		228,288
Senior unsecured notes⁽¹⁾	6,401,502		6,493,760		6,396,451		6,737,825
Mortgage debt⁽²⁾	140,321		135,044		144,486		125,984
Other debt⁽²⁾	93,070		93,070		94,165		94,165
Interest-rate swap liabilities⁽²⁾	1,706		1,706		2,483		2,483
Cross currency swap liability⁽²⁾	—		—		10,968		10,968

_______________________________________


(1)	Level 1: Fair value calculated based on quoted prices in active markets.

(2)

Level 2: Fair value based on (i) for marketable debt securities, quoted prices for similar or identical instruments in active or inactive markets, respectively, or (ii) for loans receivable, net, mortgage debt, and swaps, calculated utilizing standardized pricing models in which significant inputs or value drivers are observable in active markets. For bank line of credit, term loan and other debt, the carrying values are a reasonable estimate of fair value because the borrowings are primarily based on market interest rates and the Company’s credit rating.


(3)	During the six months ended June 30, 2018 and year ended December 31, 2017, there were no material transfers of financial assets or liabilities within the fair value hierarchy.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details